(VIANEWS) - Westport Fuel Systems (WPRT), Champions Oncology (CSBR), Federal Signal Corporation (FSS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Westport Fuel Systems (WPRT)
24.9% sales growth and 8.02% return on equity
Westport Fuel Systems Inc. designs, manufactures and supplies fuel alternatives and component for transportation applications around the world.
Westport Fuel Systems's sales growth this year is anticipated to be 38.9% and 20.3% for next year.
Year-on-year quarterly revenue growth declined by 1.5%, now sitting on 312.41M for the twelve trailing months.
Volume
Today's last reported volume for Westport Fuel Systems is 4205200 which is 65.63% above its average volume of 2538810.
Westport Fuel Systems's sales growth for the next quarter is 24.9%. The company's growth estimates for the current quarter and the next is a negative 100% and 33.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.02%.
Volatility
Westport Fuel Systems's last day, last week, and last month's current intraday variation average was 3.49%, 6.25%, and 6.06%, respectively.
Westport Fuel Systems's highest amplitude of average volatility was 8.59% (day), 10.36% (last week), and 9.29% (last month), respectively.
Westport Fuel Systems's Stock Yearly Top and Bottom Value
Westport Fuel Systems's stock is valued at $1.72 at 06:22 EST, way below its 52-week high of $8.97 and way above its 52-week low of $1.33.
Westport Fuel Systems's Moving Average
Westport Fuel Systems's worth is under its 50-day moving average of $1.77 and way below its 200-day moving average of $3.20.2. Champions Oncology (CSBR)
21.1% sales growth and 5.23% return on equity
Champions Oncology, Inc. designs and sells products and technology to help personalize the use and development of oncology medicines in the United States.
Champions Oncology's sales growth this year is anticipated to be 17.7% and 17.2% for next year.
Year-on-year quarterly revenue growth grew by 16.5%, now sitting on 44.41M for the twelve trailing months.
Volume
Today's last reported volume for Champions Oncology is 11476 which is 49.71% above its average volume of 7665.
Champions Oncology's sales growth is a negative 0% for the ongoing quarter and 21.1% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 60% and 175%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.23%.
Volatility
Champions Oncology's last day, last week, and last month's current intraday variation average was 0.24%, 3.28%, and 2.08%, respectively.
Champions Oncology's highest amplitude of average volatility was 4.36% (day), 9.15% (last week), and 7.18% (last month), respectively.
Champions Oncology's Stock Yearly Top and Bottom Value
Champions Oncology's stock is valued at $8.46 at 06:22 EST, way below its 52-week high of $13.14 and way above its 52-week low of $7.06.
Champions Oncology's Moving Average
Champions Oncology's worth is higher than its 50-day moving average of $7.96 and below its 200-day moving average of $9.20.3. Federal Signal Corporation (FSS)
19.4% sales growth and 13.54% return on equity
Federal Signal Corporation and its subsidiaries design, manufacture, and supply a range of products and solutions to municipal, governmental and industrial customers throughout the United States and Canada.
Federal Signal Corporation's sales growth this year is anticipated to be 15.6% and 8.3% for next year.
Year-on-year quarterly revenue growth grew by 2.2%, now sitting on 1.21B for the twelve trailing months.
Volume
Today's last reported volume for Federal Signal Corporation is 357474 which is 21.1% above its average volume of 295181.
Federal Signal Corporation's sales growth for the next quarter is 19.4%. The company's growth estimates for the present quarter and the next is a negative 28.9% and negative -2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.54%.
Volatility
Federal Signal Corporation's last day, last week, and last month's current intraday variation average was 1.02%, 0.50%, and 1.56%, respectively.
Federal Signal Corporation's highest amplitude of average volatility was 1.76% (day), 1.96% (last week), and 3.22% (last month), respectively.
Federal Signal Corporation's Stock Yearly Top and Bottom Value
Federal Signal Corporation's stock is valued at $34.55 at 06:22 EST, way below its 52-week high of $48.88 and above its 52-week low of $33.05.
Federal Signal Corporation's Moving Average
Federal Signal Corporation's worth is under its 50-day moving average of $36.64 and way under its 200-day moving average of $40.16.4. Organogenesis Holdings (ORGO)
11.7% sales growth and 49.45% return on equity
Organogenesis Holdings Inc. is a company that develops and manufactures regenerative medicine solutions in the United States.
Organogenesis Holdings 's sales growth this year is expected to be 6.1% and 11.2% for next year.
Year-on-year quarterly revenue growth grew by 20.4%, now sitting on 468.06M for the twelve trailing months.
Volume
Today's last reported volume for Organogenesis Holdings is 853090 which is 18.83% below its average volume of 1051030.
Organogenesis Holdings 's sales growth for the next quarter is 11.7%. The company's growth estimates for the current quarter and the next is a negative 28.6% and negative -26.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 49.45%.
Volatility
Organogenesis Holdings 's last day, last week, and last month's current intraday variation average was 5.66%, 3.75%, and 4.44%, respectively.
Organogenesis Holdings 's highest amplitude of average volatility was 6.15% (day), 5.46% (last week), and 6.89% (last month), respectively.
Organogenesis Holdings 's Stock Yearly Top and Bottom Value
Organogenesis Holdings 's stock is valued at $7.34 at 06:22 EST, way under its 52-week high of $24.34 and way higher than its 52-week low of $6.37.
Organogenesis Holdings 's Moving Average
Organogenesis Holdings 's worth is below its 50-day moving average of $7.66 and way below its 200-day moving average of $11.84.5. Novo Nordisk A/S (NVO)
11.2% sales growth and 70.63% return on equity
Novo Nordisk A/S is a global healthcare company that specializes in research, development and manufacture of pharmaceutical products.
Novo Nordisk A/S's sales growth this year is anticipated to be 7.3% and 8.3% for next year.
Year-on-year quarterly revenue growth grew by 10.1%, now sitting on 129.91B for the twelve trailing months.
Volume
Today's last reported volume for Novo Nordisk A/S is 1090400 which is 28.14% below its average volume of 1517510.
Novo Nordisk A/S's sales growth for the next quarter is 11.2%. The company's growth estimates for the ongoing quarter and the next is 6.9% and 12.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 70.63%.
Volatility
Novo Nordisk A/S's last day, last week, and last month's current intraday variation average was 2.12%, 2.12%, and 1.64%, respectively.
Novo Nordisk A/S's highest amplitude of average volatility was 1.91% (day), 1.82% (last week), and 1.59% (last month), respectively.
Novo Nordisk A/S's Stock Yearly Top and Bottom Value
Novo Nordisk A/S's stock is valued at $112.29 at 06:22 EST, under its 52-week high of $115.95 and way above its 52-week low of $66.59.
Novo Nordisk A/S's Moving Average
Novo Nordisk A/S's worth is higher than its 50-day moving average of $107.59 and way higher than its 200-day moving average of $90.32.6. Masonite International Corporation Ordinary Shares (DOOR)
9.3% sales growth and 14.22% return on equity
Masonite International Corporation manufactures, markets and distributes exterior and interior doors worldwide for new and existing construction, repair, renovation and remodeling.
Masonite International Corporation Ordinary Shares's sales growth this year is anticipated to be 8.5% and 5.2% for next year.
Year-on-year quarterly revenue growth grew by 2.8%, now sitting on 2.6B for the twelve trailing months.
Volume
Today's last reported volume for Masonite International Corporation Ordinary Shares is 137390 which is 11.71% below its average volume of 155627.
Masonite International Corporation Ordinary Shares's sales growth for the next quarter is 9.3%. The company's growth estimates for the present quarter and the next is 1.6% and 16.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.22%.
Masonite International Corporation Ordinary Shares's Stock Yearly Top and Bottom Value
Masonite International Corporation Ordinary Shares's stock is valued at $91.30 at 06:22 EST, way below its 52-week high of $132.22 and higher than its 52-week low of $85.17.
Masonite International Corporation Ordinary Shares's Moving Average
Masonite International Corporation Ordinary Shares's value is under its 50-day moving average of $97.11 and way below its 200-day moving average of $109.68.7. Dover Corporation (DOV)
9.1% sales growth and 26.42% return on equity
Dover Corporation offers equipment and components as well as consumable supplies, spare parts, digital solutions and aftermarket parts.
Dover Corporation's sales growth this year is expected to be 17.5% and 4.9% for next year.
Year-on-year quarterly revenue growth grew by 15.4%, now sitting on 7.7B for the twelve trailing months.
Volume
Today's last reported volume for Dover Corporation is 410673 which is 48.92% below its average volume of 803980.
Dover Corporation's sales growth for the next quarter is 9.1%. The company's growth estimates for the ongoing quarter and the next is 19.4% and 11%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.42%.
Volatility
Dover Corporation's last day, last week, and last month's current intraday variation average was 1.35%, 1.84%, and 0.94%, respectively.
Dover Corporation's highest amplitude of average volatility was 1.42% (day), 1.53% (last week), and 1.42% (last month), respectively.
Dover Corporation's Stock Yearly Top and Bottom Value
Dover Corporation's stock is valued at $160.23 at 06:22 EST, way below its 52-week high of $178.32 and way above its 52-week low of $115.88.